Neos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NEOS and buy or sell other stocks, ETFs, and their options commission-free!About NEOS
Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform.
CEOGerald W. McLaughlin, MBA
CEOGerald W. McLaughlin, MBA
Employees—
Employees—
HeadquartersGrand Prairie, Texas
HeadquartersGrand Prairie, Texas
Founded1994
Founded1994
Employees—
Employees—
NEOS Key Statistics
Market cap57.22M
Market cap57.22M
Price-Earnings ratio-2.62
Price-Earnings ratio-2.62
Dividend yield—
Dividend yield—
Average volume18.69M
Average volume18.69M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.68
52 Week high$1.68
52 Week low$0.4501
52 Week low$0.4501
People also own
Based on the portfolios of people who own NEOS. This list is generated using Robinhood data, and it’s not a recommendation.